The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic role of estrogen receptor (ER) expression in breast cancer (BC) metastases and its dynamics from primary to metastatic disease: Results from a large multicentric cohort of patients with phenotypically stable ER+(=10%)/HER2- BC.
 
Federica Miglietta
Consulting or Advisory Role - AstraZeneca; MSD
Speakers' Bureau - Gilead Sciences; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Gilead Sciences; Novartis
 
Claudio Vernieri
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Menarini Group; Novartis; Pfizer
Speakers' Bureau - Accademia Nazionale Di Medicina (ACCMED); AstraZeneca; Istituto Gentili; Lilly; Menarini Group; MSD; Novartis; Pfizer
Research Funding - Roche
 
Federico Piacentini
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Roche; Seagen
Expert Testimony - Gilead Sciences
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Novartis; Roche
Other Relationship - Pfizer
 
Matilde Cacciatore
No Relationships to Disclose
 
Andrea Vingiani
Honoraria - Lilly; Roche
 
Giuseppe Fotia
No Relationships to Disclose
 
Andrea Botticelli
No Relationships to Disclose
 
Lorenzo Nicolè
No Relationships to Disclose
 
Gaia Griguolo
Consulting or Advisory Role - Gilead Sciences; Menarini; Seagen
Speakers' Bureau - Lilly; MSD
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer
 
Tommaso Giarratano
Honoraria - Genetic Spa; IQVIA; Lilly
 
Davide Massa
Travel, Accommodations, Expenses - Lilly
 
Carlo Alberto Giorgi
Honoraria - Lilly; MSD; Novartis; Seagen/Pfizer
 
Giovanni Faggioni
Honoraria - AstraZeneca Canada
 
Pietro Napolitano
No Relationships to Disclose
 
Marina La Commare
No Relationships to Disclose
 
Matteo Fassan
Consulting or Advisory Role - Amgen; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Diapath; GlaxoSmithKline; Incyte; IQvia; Janssen; Lilly; MSD Oncology; Novartis; Pierre Fabre; Roche
Research Funding - Astellas Pharma; Diaceutics
 
Giancarlo Pruneri
Honoraria - AstraZeneca; Genomic Health; Menarini; Novartis; Roche
Consulting or Advisory Role - ADS Biotec; ADS Biotec; ADS Biotec
Research Funding - Roche; Roche Molecular Diagnostics
 
Angelo Dei Tos
No Relationships to Disclose
 
Valentina Guarneri
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; Merck Serono; MSD; Novartis; Olema Oncology; Pierre Fabre
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini Steamline; Novartis; Roche; Zentiva
Research Funding - AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Synthon (Inst)
Expert Testimony - Lilly
Travel, Accommodations, Expenses - AstraZeneca; Gilead/Forty Seven
 
Maria Vittoria Dieci
Honoraria - Lilly
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending HER2DX licensed to University of Padova
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Roche